Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands
Authors:
Open Access
- 2 April 2022
- journal article
- research article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 31, 100553
Abstract
No abstract availableKeywords
Funding Information
- ZonMw (10,430,022,010,014)
This publication has 15 references indexed in Scilit:
- Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 PandemicEuropean Urology Focus, 2020
- The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancerFuture Oncology, 2020
- European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 EraEuropean Urology, 2020
- Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Advances in Radiation Oncology, 2020
- The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic CarcinomaAmerican Journal of Surgical Pathology, 2020
- Fewer cancer diagnoses during the COVID-19 epidemic in the NetherlandsThe Lancet Oncology, 2020
- Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical StudyEuropean Urology, 2019
- Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trialThe Lancet, 2018
- Skin Tumours2017
- Pathology Databanking and Biobanking in The Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and ArchiveAnalytical Cellular Pathology, 2007